As of 2024-07-27, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 81.49 USD. This relative valuation is based on P/E multiples. With the latest stock price at 56.23 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 44.9%.
The range of the Relative Valuation is 77.15 - 86.09 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | 77.15 - 86.09 | 81.49 |
| Upside | 37.2% - 53.1% | 44.9% |
| Date | P/E |
| 2024-07-26 | 22.45 |
| 2024-07-25 | 22.34 |
| 2024-07-24 | 22.02 |
| 2024-07-23 | 22.12 |
| 2024-07-22 | 21.69 |
| 2024-07-19 | 21.57 |
| 2024-07-18 | 21.68 |
| 2024-07-17 | 21.86 |
| 2024-07-16 | 22.00 |
| 2024-07-15 | 20.98 |
| 2024-07-12 | 21.23 |
| 2024-07-11 | 21.09 |
| 2024-07-10 | 21.14 |
| 2024-07-09 | 21.11 |
| 2024-07-08 | 20.98 |
| 2024-07-05 | 20.58 |
| 2024-07-03 | 20.76 |
| 2024-07-02 | 20.48 |
| 2024-07-01 | 20.77 |
| 2024-06-28 | 20.90 |
| 2024-06-27 | 20.61 |
| 2024-06-26 | 20.76 |
| 2024-06-25 | 20.92 |
| 2024-06-24 | 20.78 |
| 2024-06-21 | 20.58 |
| 2024-06-20 | 20.30 |
| 2024-06-18 | 20.07 |
| 2024-06-17 | 19.82 |
| 2024-06-14 | 19.76 |
| 2024-06-13 | 19.81 |
| 2024-06-12 | 19.82 |
| 2024-06-11 | 19.93 |
| 2024-06-10 | 20.42 |
| 2024-06-07 | 20.30 |
| 2024-06-06 | 20.53 |
| 2024-06-05 | 18.22 |
| 2024-06-04 | 17.68 |
| 2024-06-03 | 17.98 |
| 2024-05-31 | 17.68 |
| 2024-05-30 | 17.31 |
| 2024-05-29 | 17.07 |
| 2024-05-28 | 17.20 |
| 2024-05-24 | 17.49 |
| 2024-05-23 | 17.53 |
| 2024-05-22 | 18.16 |
| 2024-05-21 | 18.18 |
| 2024-05-20 | 17.95 |
| 2024-05-17 | 17.85 |
| 2024-05-16 | 18.12 |
| 2024-05-15 | 18.29 |